Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting125%
completed250%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane

NCT05575024
completednot_applicable

The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO

NCT05642273
completednot_applicable

Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated With Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX

NCT04886180
unknownnot_applicable

The Effects of Oxiris on Systemic Inflammation and Endothelial dysFunction

NCT04257006

Clinical Trials (4)

Showing 4 of 4 trials
NCT05575024

Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane

Recruiting
NCT05642273Not Applicable

The Effects of oXiris in Cardiogenic Shock Requiring VA-ECMO

Completed
NCT04886180Not Applicable

Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated With Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX

Completed
NCT04257006Not Applicable

The Effects of Oxiris on Systemic Inflammation and Endothelial dysFunction

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4